HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Bioscience, Inc. (NASDAQ: HBIO) announced today that its Board of Directors has adopted a Shareholder Rights Plan. Chane Graziano, Harvard Bioscience, Inc.’s Chief Executive Officer, stated, “The Board believes that a Shareholders Rights Plan enhances its ability to protect shareholder interests and ensures that shareholders receive fair treatment in the event of any coercive takeover attempt. The Plan is intended to provide the Board with sufficient time to consider any and all alternatives to such an action. The Board believes it is protecting the interests of all of its shareholders.”
